Literature DB >> 22120640

Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation.

Alison M Taylor1, Jessica M Humphries, Richard M White, Ryan D Murphey, Caroline E Burns, Leonard I Zon.   

Abstract

Disruption of ribosomal proteins is associated with hematopoietic phenotypes in cell culture and animal models. Mutations in ribosomal proteins are seen in patients with Diamond Blackfan anemia, a rare congenital disease characterized by red cell aplasia and distinctive craniofacial anomalies. A zebrafish screen uncovered decreased hematopoietic stem cells in embryos with mutations in ribosomal protein rps29. Here, we determined that rps29(-/-) embryos also have red blood cell defects and increased apoptosis in the head. As the p53 pathway has been shown to play a role in other ribosomal protein mutants, we studied the genetic relationship of rps29 and p53. Transcriptional profiling revealed that genes upregulated in the rps29 mutant are enriched for genes upregulated by p53 after irradiation. p53 mutation near completely rescues the rps29 morphological and hematopoietic phenotypes, demonstrating that p53 mediates the effects of rps29 knockdown. We also identified neuronal gene orthopedia protein a (otpa) as one whose expression correlates with rps29 expression, suggesting that levels of expression of some genes are dependent on rps29 levels. Together, our studies demonstrate a role of p53 in mediating the cellular defects associated with rps29 and establish a role for rps29 and p53 in hematopoietic stem cells and red blood cell development. Copyright Â
© 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120640      PMCID: PMC3310385          DOI: 10.1016/j.exphem.2011.11.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  36 in total

1.  Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling.

Authors:  Ulrike Langheinrich; Elisabeth Hennen; Gordon Stott; Gabi Vacun
Journal:  Curr Biol       Date:  2002-12-10       Impact factor: 10.834

2.  Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.

Authors:  Leana Doherty; Mee Rie Sheen; Adrianna Vlachos; Valerie Choesmel; Marie-Françoise O'Donohue; Catherine Clinton; Hal E Schneider; Colin A Sieff; Peter E Newburger; Sarah E Ball; Edyta Niewiadomska; Michal Matysiak; Bertil Glader; Robert J Arceci; Jason E Farrar; Eva Atsidaftos; Jeffrey M Lipton; Pierre-Emmanuel Gleizes; Hanna T Gazda
Journal:  Am J Hum Genet       Date:  2010-01-28       Impact factor: 11.025

3.  Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia.

Authors:  Hidetsugu Torihara; Tamayo Uechi; Anirban Chakraborty; Minori Shinya; Noriyoshi Sakai; Naoya Kenmochi
Journal:  Br J Haematol       Date:  2011-01-12       Impact factor: 6.998

4.  Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.

Authors:  Nadia Danilova; Kathleen M Sakamoto; Shuo Lin
Journal:  Br J Haematol       Date:  2010-11-29       Impact factor: 6.998

5.  Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation.

Authors:  Hans Matsson; Edward J Davey; Natalia Draptchinskaia; Isao Hamaguchi; Andreas Ooka; Per Levéen; Erik Forsberg; Stefan Karlsson; Niklas Dahl
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  Identification of 315 genes essential for early zebrafish development.

Authors:  Adam Amsterdam; Robert M Nissen; Zhaoxia Sun; Eric C Swindell; Sarah Farrington; Nancy Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

7.  Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.

Authors:  Stefano Fumagalli; Alessandro Di Cara; Arti Neb-Gulati; Francois Natt; Sandy Schwemberger; Jonathan Hall; George F Babcock; Rosa Bernardi; Pier Paolo Pandolfi; George Thomas
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

8.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects.

Authors:  Kelly A McGowan; Jun Z Li; Christopher Y Park; Veronica Beaudry; Holly K Tabor; Amit J Sabnis; Weibin Zhang; Helmut Fuchs; Martin Hrabé de Angelis; Richard M Myers; Laura D Attardi; Gregory S Barsh
Journal:  Nat Genet       Date:  2008-07-20       Impact factor: 38.330

Review 9.  The mitochondrial p53 pathway.

Authors:  Angelina V Vaseva; Ute M Moll
Journal:  Biochim Biophys Acta       Date:  2008-10-25

10.  A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis.

Authors:  Shintaro Imamura; Junzo Uchiyama; Eriko Koshimizu; Jun-Ichi Hanai; Christina Raftopoulou; Ryan D Murphey; Peter E Bayliss; Yoichi Imai; Caroline Erter Burns; Kenkichi Masutomi; Sarantis Gagos; Leonard I Zon; Thomas M Roberts; Shuji Kishi
Journal:  PLoS One       Date:  2008-10-10       Impact factor: 3.240

View more
  43 in total

1.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

2.  FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination.

Authors:  Cynthia L Neben; Creighton T Tuzon; Xiaojing Mao; Fides D Lay; Amy E Merrill
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

3.  Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.

Authors:  Loïc Garçon; Jingping Ge; Shwetha H Manjunath; Jason A Mills; Marisa Apicella; Shefali Parikh; Lisa M Sullivan; Gregory M Podsakoff; Paul Gadue; Deborah L French; Philip J Mason; Monica Bessler; Mitchell J Weiss
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

Review 4.  Ribosomal proteins: functions beyond the ribosome.

Authors:  Xiang Zhou; Wen-Juan Liao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2015-03-03       Impact factor: 6.216

Review 5.  A liaison between mTOR signaling, ribosome biogenesis and cancer.

Authors:  Antonio Gentilella; Sara C Kozma; George Thomas
Journal:  Biochim Biophys Acta       Date:  2015-02-28

6.  Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.

Authors:  Sergei Doulatov; Linda T Vo; Elizabeth R Macari; Lara Wahlster; Melissa A Kinney; Alison M Taylor; Jessica Barragan; Manav Gupta; Katherine McGrath; Hsiang-Ying Lee; Jessica M Humphries; Alex DeVine; Anupama Narla; Blanche P Alter; Alan H Beggs; Suneet Agarwal; Benjamin L Ebert; Hanna T Gazda; Harvey F Lodish; Colin A Sieff; Thorsten M Schlaeger; Leonard I Zon; George Q Daley
Journal:  Sci Transl Med       Date:  2017-02-08       Impact factor: 17.956

7.  tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.

Authors:  Kristin E N Watt; Cynthia L Neben; Shawn Hall; Amy E Merrill; Paul A Trainor
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

8.  Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs.

Authors:  Yong Zhang; Anne-Cécile E Duc; Shuyun Rao; Xiao-Li Sun; Alison N Bilbee; Michele Rhodes; Qin Li; Dietmar J Kappes; Jennifer Rhodes; David L Wiest
Journal:  Dev Cell       Date:  2013-02-25       Impact factor: 12.270

Review 9.  Understanding the regulation of vertebrate hematopoiesis and blood disorders - big lessons from a small fish.

Authors:  Anne L Robertson; Serine Avagyan; John M Gansner; Leonard I Zon
Journal:  FEBS Lett       Date:  2016-09-25       Impact factor: 4.124

Review 10.  Genomic characterization of the inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.